Abstract 1691: Synergistic anti-tumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
Authors:
- Alexandra MorosAMAlexandra Moros
- Vanina RodriguezVRVanina Rodriguez
- Ifigenia Saborit-VillarroyaISIfigenia Saborit-Villarroya
- Arnau MontravetaAMArnau Montraveta
- Patricia BalsasPBPatricia Balsas
- Peter SandyPSPeter Sandy
- Antonio MartinezAMAntonio Martinez
- Emmanuel NormantENEmmanuel Normant
- Patricia Perez-GalanPPPatricia Perez-Galan
- Elias CampoECElias Campo
- Dolors ColomerDCDolors Colomer
- Gael RoueGael Roue
- 30 September 2014
- conference paper
- Published by American Association for Cancer Research (AACR)